Published in Blood on November 01, 2008
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science (2010) 4.67
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest (2011) 2.54
Therapeutic genome editing: prospects and challenges. Nat Med (2015) 2.42
Advances in understanding tissue regenerative capacity and mechanisms in animals. Nat Rev Genet (2010) 2.28
Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A (2010) 2.27
CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest (2010) 1.97
CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest (2010) 1.82
An information theoretic, microfluidic-based single cell analysis permits identification of subpopulations among putatively homogeneous stem cells. PLoS One (2011) 1.47
Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) (2011) 1.46
Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. Leukemia (2011) 1.44
Poised Regeneration of Zebrafish Melanocytes Involves Direct Differentiation and Concurrent Replenishment of Tissue-Resident Progenitor Cells. Dev Cell (2015) 1.38
DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc Natl Acad Sci U S A (2013) 1.37
Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice. PLoS One (2011) 1.24
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis. Blood (2011) 1.23
Critical roles of lysosomal acid lipase in myelopoiesis. Am J Pathol (2010) 1.22
Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc (2013) 1.21
Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell (2010) 1.21
Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells. Proc Natl Acad Sci U S A (2013) 1.19
Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell (2014) 1.15
Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice. J Immunol (2011) 1.15
Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression, and lung tumorigenesis. Blood (2011) 1.14
A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood (2010) 1.14
Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol (2009) 1.08
Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface (2010) 1.06
Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood (2014) 1.06
Mechanobiology of bone marrow stem cells: from myosin-II forces to compliance of matrix and nucleus in cell forms and fates. Differentiation (2013) 1.04
Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/- mice. Am J Pathol (2013) 1.02
Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells. J Clin Invest (2015) 1.00
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification. Blood (2011) 1.00
Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc Natl Acad Sci U S A (2014) 0.99
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? J Hematol Oncol (2015) 0.96
Proteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells. Mol Cell Proteomics (2012) 0.96
Defective regulation of CXCR2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice. J Immunol (2010) 0.95
CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells. Leukemia (2013) 0.94
Cyclin C regulates human hematopoietic stem/progenitor cell quiescence. Stem Cells (2010) 0.93
Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater (2011) 0.93
Hematopoietic stem cells and retroviral infection. Retrovirology (2010) 0.91
Umbilical cord transplantation: epilogue. Semin Hematol (2010) 0.90
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation. Gene Ther (2009) 0.89
Regenerative Effects of Mesenchymal Stem Cells: Contribution of Muse Cells, a Novel Pluripotent Stem Cell Type that Resides in Mesenchymal Cells. Cells (2012) 0.89
Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol (2010) 0.89
Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy. Parkinsons Dis (2012) 0.89
Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not Id1 deficient mice. PLoS One (2013) 0.87
Stem cell therapy: an exercise in patience and prudence. Philos Trans R Soc Lond B Biol Sci (2013) 0.86
Small molecules and stem cells. Potency and lineage commitment: the new quest for the fountain of youth. J Med Chem (2010) 0.86
Urothelial carcinoma: stem cells on the edge. Cancer Metastasis Rev (2009) 0.86
Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner. Exp Hematol (2014) 0.85
Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE-/- Mice. Circ Res (2016) 0.84
Stem cell-like differentiation potentials of endometrial side population cells as revealed by a newly developed in vivo endometrial stem cell assay. PLoS One (2012) 0.84
The hematopoietic system in the context of regenerative medicine. Methods (2015) 0.84
Hematopoietic stem cells in research and clinical applications: The "CD34 issue". World J Stem Cells (2010) 0.83
Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation. Haematologica (2010) 0.83
Cell-intrinsic in vivo requirement for the E47-p21 pathway in long-term hematopoietic stem cells. J Immunol (2013) 0.83
The Transcription Factor ARID3a Is Important for In Vitro Differentiation of Human Hematopoietic Progenitors. J Immunol (2015) 0.83
Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies. Int J Hematol Oncol Stem Cell Res (2013) 0.83
Phenotypic definition of the progenitor cells with erythroid differentiation potential present in human adult blood. Stem Cells Int (2011) 0.82
High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. J Vis Exp (2014) 0.82
Hierarchal Autophagic Divergence of Hematopoietic System. J Biol Chem (2015) 0.81
Hematopoietic Stem Cells in Regenerative Medicine: Astray or on the Path? Transfus Med Hemother (2016) 0.81
Mesenchymal progenitors and the osteoblast lineage in bone marrow hematopoietic niches. Curr Osteoporos Rep (2014) 0.81
Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis. Stem Cell Reports (2015) 0.80
The role of transcription factors in the guidance of granulopoiesis. Am J Blood Res (2012) 0.80
Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic-like stem cells in human cord blood. Leukemia (2015) 0.80
Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. Proteomics (2011) 0.80
Cell-based therapy technology classifications and translational challenges. Philos Trans R Soc Lond B Biol Sci (2015) 0.80
Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges. J R Soc Interface (2010) 0.80
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood (2016) 0.80
Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science. Biotechnol J (2015) 0.80
Mapping mouse hemangioblast maturation from headfold stages. Dev Biol (2012) 0.80
Reprogramming of embryonic human fibroblasts into fetal hematopoietic progenitors by fusion with human fetal liver CD34+ cells. PLoS One (2011) 0.79
Strategies for enrichment and selection of stem cell-derived tissue precursors. Stem Cell Res Ther (2012) 0.79
Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia (2012) 0.79
Osteoclast precursors in murine bone marrow express CD27 and are impeded in osteoclast development by CD70 on activated immune cells. Proc Natl Acad Sci U S A (2013) 0.79
The Instructive Role of the Vasculature in Stem Cell Niches. Biomater Sci (2014) 0.79
The dynamic interplay between a PTK (Kit) and a PTP (Shp2) in hematopoietic stem and progenitor cells. Cell Cycle (2011) 0.78
Muse cells and induced pluripotent stem cell: implication of the elite model. Cell Mol Life Sci (2012) 0.78
A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice. Blood (2009) 0.78
Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs). Organogenesis (2013) 0.78
Bone marrow-derived hematopoietic stem and progenitor cells infiltrate allogeneic and syngeneic transplants. Am J Transplant (2014) 0.78
The epigenetic regulator CXXC finger protein 1 is essential for murine hematopoiesis. PLoS One (2014) 0.77
Transcriptome-wide profiling and posttranscriptional analysis of hematopoietic stem/progenitor cell differentiation toward myeloid commitment. Stem Cell Reports (2014) 0.77
Cellular therapy for repair of cardiac damage after acute myocardial infarction. Int J Cell Biol (2009) 0.77
Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts. Stem Cells (2013) 0.77
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application. Mol Ther Methods Clin Dev (2016) 0.76
Challenges and Opportunities to Harnessing the (Hematopoietic) Stem Cell Niche. Curr Stem Cell Rep (2016) 0.76
The Role of Physical Stabilization in Whole Blood Preservation. Sci Rep (2016) 0.76
Defining a stem cell hierarchy in the intestine: markers, caveats and controversies. J Physiol (2016) 0.76
Gene expression profile and functionality of ESC-derived Lin-ckit+Sca-1+ cells are distinct from Lin-ckit+Sca-1+ cells isolated from fetal liver or bone marrow. PLoS One (2012) 0.75
Utilization of imaging flow cytometry to define intermediates of megakaryopoiesis in vivo and in vitro. J Immunol Methods (2015) 0.75
Quantitative Stability of Hematopoietic Stem and Progenitor Cell Clonal Output in Transplanted Rhesus Macaques. Blood (2017) 0.75
Developmental cell death programs license cytotoxic cells to eliminate histocompatible partners. Proc Natl Acad Sci U S A (2016) 0.75
Blood and immune cell engineering: Cytoskeletal contractility and nuclear rheology impact cell lineage and localization: Biophysical regulation of hematopoietic differentiation and trafficking. Bioessays (2015) 0.75
Methotrexate supports in vivo selection of human embryonic stem cell derived-hematopoietic cells expressing dihydrofolate reductase. Bioeng Bugs (2011) 0.75
Assessment of human multi-potent hematopoietic stem/progenitor cell potential using a single in vitro screening system. PLoS One (2012) 0.75
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Int J Mol Sci (2016) 0.75
Mesenchymal stem cells in post-surgical cavities of large maxillary bone lesions. Clin Cases Miner Bone Metab (2017) 0.75
Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell. Exp Hematol (2016) 0.75
Two-dimensional polymer-based cultures expand cord blood-derived hematopoietic stem cells and support engraftment of NSG mice. Tissue Eng Part C Methods (2012) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Actively acquired tolerance of foreign cells. Nature (1953) 19.82
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature (2000) 16.75
Purification and characterization of mouse hematopoietic stem cells. Science (1988) 15.99
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell (1997) 12.60
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med (2004) 11.29
Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88
The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity (1994) 9.50
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (1988) 9.05
The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells (1978) 8.80
Cytological identification of radiation-chimaeras. Nature (1956) 8.76
Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol (1977) 6.82
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res (2006) 6.77
Developmental potential and dynamic behavior of hematopoietic stem cells. Cell (1986) 5.98
Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell (2007) 5.28
Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature (1963) 5.23
Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell (2004) 5.20
Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell (2008) 4.92
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood (2001) 4.65
B220: a B cell-specific member of th T200 glycoprotein family. Nature (1981) 4.65
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol (1984) 4.55
Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell (1999) 4.54
Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A (1992) 4.28
Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell (1992) 4.26
Protective conditioning for acute graft-versus-host disease. N Engl J Med (2005) 4.07
Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A (1992) 4.06
Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells of the lymphoid system. J Exp Med (1968) 3.97
Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat (2001) 3.96
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A (1997) 3.84
Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med (2003) 3.74
Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci U S A (1982) 3.74
Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci U S A (1997) 3.74
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A (2000) 3.68
Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell (2007) 3.59
Isolation of murine pluripotent hemopoietic stem cells. J Exp Med (1984) 3.56
Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity (1995) 3.51
Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A (2002) 3.50
Isolation of two early B lymphocyte progenitors from mouse marrow: a committed pre-pre-B cell and a clonogenic Thy-1-lo hematopoietic stem cell. Cell (1986) 3.46
THE DISTRIBUTION OF COLONY-FORMING CELLS AMONG SPLEEN COLONIES. J Cell Physiol (1963) 3.36
The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol (2000) 3.31
Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule. Cell (1987) 3.15
Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A (1991) 3.14
A monoclonal antibody that recognizes B cells and B cell precursors in mice. J Exp Med (1981) 3.13
Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med (1971) 3.10
Identification of a lineage of multipotent hematopoietic progenitors. Development (1997) 3.01
A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J Cell Physiol (1967) 2.84
Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood (2001) 2.75
Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (2000) 2.71
Transient nature of early haematopoietic spleen colonies. Nature (1982) 2.70
Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science (2007) 2.69
Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest (1988) 2.53
Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood (1989) 2.44
New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell (2006) 2.34
Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood (2003) 2.29
Stem cell research: paths to cancer therapies and regenerative medicine. JAMA (2005) 2.25
Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci U S A (1989) 2.24
Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest (2002) 2.22
Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst (1951) 2.13
The fate of mouse spleen cells transplanted into homologous and F1 hybrid hosts. Immunology (1959) 2.11
Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res (2002) 2.07
Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood (2008) 2.06
Murine natural killer cells and marrow graft rejection. Annu Rev Immunol (1992) 1.87
Haematopoiesis. Searching for stem cells. Nature (1990) 1.87
Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning. J Exp Med (2005) 1.77
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol (2000) 1.77
Characterization of mouse clonogenic megakaryocyte progenitors. Proc Natl Acad Sci U S A (2002) 1.70
Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells. Blood (1994) 1.66
Bone marrow cells give rise to distinct cell clones within the thymus. Nature (1984) 1.62
Identification of a novel, human multilymphoid progenitor in cord blood. Blood (2001) 1.56
Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol Blood Marrow Transplant (1996) 1.48
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant (2000) 1.48
The role of the spleen in radiation injury and recovery. J Lab Clin Med (1950) 1.47
Two rare populations of mouse Thy-1lo bone marrow cells repopulate the thymus. J Exp Med (1988) 1.42
CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity (1999) 1.41
Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol (2002) 1.27
Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci U S A (1974) 1.27
Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci U S A (1982) 1.25
High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J Clin Invest (1998) 1.22
Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood (2002) 1.21
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood (2003) 1.19
Recovery from radiation injury. Science (1951) 1.18
Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes (2003) 1.17
The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood (1997) 1.17
T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes. Leukemia (2006) 1.10
An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur J Immunol (1986) 1.10
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Mature T cells generated from single thymic clones are phenotypically and functionally heterogeneous. J Immunol (1988) 1.07
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2001) 1.04
An in vivo assay for thymus-homing bone marrow cells. Nature (1981) 1.04
Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol (2002) 7.78
Protective conditioning for acute graft-versus-host disease. N Engl J Med (2005) 4.07
Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med (2008) 4.04
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J Clin Oncol (2005) 2.15
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2005) 2.12
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood (2003) 2.08
Induced immune tolerance for kidney transplantation. N Engl J Med (2011) 2.08
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J Clin Oncol (2010) 2.07
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 1.96
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation (2002) 1.86
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. J Clin Oncol (2006) 1.63
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood (2008) 1.59
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood (2003) 1.55
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. Biol Blood Marrow Transplant (2006) 1.54
Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells. Biol Blood Marrow Transplant (2011) 1.49
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. Blood (2012) 1.31
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood (2003) 1.19
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation. Br J Haematol (2005) 1.18
Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes (2003) 1.17
Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes. Proc Natl Acad Sci U S A (2006) 1.17
Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood (2002) 1.07
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood (2004) 1.02
A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies. Blood (2011) 1.01
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia. Biol Blood Marrow Transplant (2005) 0.98
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2006) 0.93
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies. Exp Hematol (2005) 0.91
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. Int J Hematol (2002) 0.89
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proc Natl Acad Sci U S A (2010) 0.88
Approaches to transplantation tolerance in humans. Transplantation (2004) 0.86
Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow. Proc Natl Acad Sci U S A (2009) 0.86
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma. Biol Blood Marrow Transplant (2010) 0.86
Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. Blood (2014) 0.85
Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants. Diabetes (2005) 0.85
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biol Blood Marrow Transplant (2009) 0.84
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Biol Blood Marrow Transplant (2007) 0.83
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning. Biol Blood Marrow Transplant (2007) 0.83
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells. Biol Blood Marrow Transplant (2005) 0.82
Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion. Radiat Res (2014) 0.82
Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation. J Immunol (2009) 0.82
Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice. Proc Natl Acad Sci U S A (2003) 0.81
The road to purified hematopoietic stem cell transplants is paved with antibodies. Curr Opin Immunol (2012) 0.80
Non-myeloablative transplantation. Hematology Am Soc Hematol Educ Program (2002) 0.80
Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice. Arthritis Rheum (2013) 0.79
Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. Proc Natl Acad Sci U S A (2012) 0.78
A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice. Blood (2009) 0.78
Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice. J Immunol (2009) 0.77
Fine mapping of the Bmgr5 quantitative trait locus for allogeneic bone marrow engraftment in mice. Immunogenetics (2013) 0.75
Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice. Immunogenetics (2013) 0.75
Rapid reconstitution of antibody responses following transplantation of purified allogeneic hematopoietic stem cells. J Immunol (2011) 0.75